Disseminated Ureaplasma urealyticum infection presenting as systemic inflammatory syndrome in ocrelizumab-treated patients with multiple sclerosis: a case series. (PubMed, J Med Case Rep) - Oct 24, 2026 - "Novel B-cell targeting agents can be effective treatments for MS; however, their use may be associated with potentially life-threatening complications. These two cases highlight the diagnostic and therapeutic challenges associated with opportunistic infections in the context of anti-CD20 monoclonal antibody therapy."
Journal • CNS Disorders • Immunology • Infectious Disease • Multiple Sclerosis • Ocular Infections • Ocular Inflammation • Ophthalmology • Rheumatology • Seronegative Spondyloarthropathies
|
|
Abdalla Abuelmagd; Anna Witkowska; Fionnuala Cahill; Geraldine McCarthy; Joanne Kitchen; John Stack; Killian O'Rourke; Padraig McGettrick; Tomas Burke
|